Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07781631 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study in Healthy Men to Test Whether Carbamazepine Influences the Amount of Verducatib in the Blood

Name: A Study in Healthy Men to Test Whether Carbamazepine Influences the Amount of Verducatib in the Blood — clinical trial record (NCT07781631)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhasePhase 1

SponsorBoehringer Ingelheim

Started2026-09-10

View on ClinicalTrials.gov ↗

Amendment history

2026-09-24

Recruitment opened

Boehringer Ingelheim

221 trials monitored

See 15 trials at risk

The main objective of this trial is to investigate the effect of carbamazepine, a strong CYP3A4 inducer on the pharmacokinetics of verducatib at steady state.

Trial Details

NCT Number	NCT07781631
Lead Sponsor	Boehringer Ingelheim
Conditions	Healthy
Enrollment	20 participants
Start Date	2026-09-10
Primary Completion	2026-12-14 (estimated)
Study Completion	2026-12-20 (estimated)
Updated on ClinicalTrials.gov	2026-09-23